People · Operator
Named in public records as an officer, director or promoter · active 2011–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mevion Medical Systems, Inc. | — | Biotechnology | Series C | $95.3M | $2.4B | 2011 |
Paul Volcker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Volcker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Wilson | 1 | 7 |
| Myles Greenberg | 1 | 6 |
| Mitchell Bloom | 1 | 6 |
| Kenneth Gall | 1 | 5 |
| Anders Hove | 1 | 4 |
| Jay Moorin | 1 | 4 |
| Marc Buntaine | 1 | 3 |
| Cheng Lu | 1 | 2 |
| Jay Rao | 1 | 1 |
| Xuan Li | 1 | 1 |
| Stephen Buckley | 1 | 1 |
| Xiaowei Chang | 1 | 1 |
| Donald Melson | 1 | 1 |
| Joseph Jachinowski | 1 | 1 |
| Peter D'Angelo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.